Search Results
7 items found for "Benign prostatic hyperplasia"
- Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
and benign prostatic hyperplasia Published date June 28, 2024 Abstract " Ethnopharmacological relevance : Prostatitis and benign prostatic hyperplasia (BPH) are inflammations of the prostate gland, which surrounds Aim of the study: We hypothesized that Jinqiancao granules could be a potential therapy for prostatitis Liangliang Zhou, Wenjie Yuan, Wanxian Wang, Yumin Yao, Jixia Wang, Yanfang Liu, Xinmiao Liang Tags Benign prostatic hyperplasia , G-protein coupled receptor , Jinqiancao granules , Network pharmacology , Prostatitis
- Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells
GPCR News < GPCRs in Oncology and Immunology Autocrine proteinase-activated receptor signaling in PC3 prostate PARs are highly expressed in many cancer cells, including prostate cancer (PCa), and regulate various In this study, we examined the androgen-independent human prostatic cancer cell line PC3 and find the
- Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia
Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia Published date December 22, 2022 Abstract Patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) usually present bilateral benign adrenocortical macronodules at imaging and variable levels Fanny Chasseloup , Peter Kamenicky , André Lacroix Tags ARMC5 , KDM1A , Cushing’s syndrome , adrenal hyperplasia
- Ep 78 with Dr. Stuart Maudsley
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional
- Ep 43 with Dr. Stuart Maudsley
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional
- Ep 72 with Dr. Stuart Maudsley
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional
- Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
(GPCR) expression is highly prevalent in cortisol-secreting primary bilateral macronodular adrenal hyperplasia